Ian D Davis
Ian D Davis, MBBS, PhD is an expert in Oncology at Eastern Health (Australia). As of October 2026, ScienceLeadR ranks Ian D Davis in the top 1% of experts worldwide for Prostatic Diseases, Urogenital Neoplasms and Urologic Neoplasms. Ian D Davis has authored 701 publications, the most recent in 2026, and is an investigator in 23 clinical trials, 2 of them ongoing. SLR score: 2,623 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Urology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Professor Ian Davis MBBS(Hons) PhD FRACP FAChPM FAHMS GAICD is a medical oncologist and has been Professor of Medicine and Head of the Monash University Eastern Health Clinical School since 2012. He is an NHMRC Leadership Fellow L3. He also holds honorary appointments as an Affiliate Professor of Deakin University, adjunct Associate Professor of the University of Melbourne, Associate of the University of Sydney, Honorary Professorial Fellow with The George Institute, and Adjunct Professor of University of New South Wales. His primary clinical interests are in urologic cancers, and his primary research interests are in cancer immunology and the biology of urologic cancers. Prof Davis is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP, www.anzup.org.au), a not-for-profit charity dedicated to improving outcomes for people affected by “below the belt” cancers of the genitourinary system (prostate, kidney, bladder, testis, penis). Prof Davis is chair of the ANZUP Board and of its Scientific Advisory Committee, and Principal Investigator of several of its trials. He has been involved in over 220 clinical trials including over 130 as global or site Principal Investigator, and has published over 340 papers including over 240 of original research, with over 28,000 citations per Google Scholar.
Organizations
Career arc: 1991 - 2026
Number : 701
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 23
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Working Out M0 Bipolar Androgen Therapy NCT06594926 — androgens, neoplasms, disease progression, prostate, testosterone, neoplasm metastasis, prostatic neoplasms, therapeutics | Phase 2 | Recruiting | 2024 |
| Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET) NCT05881135 — choline, lung, cytidine, saline solution, cytidine diphosphate, lung injury, solutions, covid-19, therapeutics, cytidine diphosphate choline | Phase 1/Phase 2 | Active not recruiting | 2023 |
LeadR Networks
Main global connection map